A Study to Evaluate the Intramuscular Administration of Scopolamine

NCT04314713 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped DSMB decision due to adverse events

Conditions

Medical Countermeasures
Organophosphate Poisoning

Interventions

DRUG: Scopolamine Hydrobromide Trihydrate

Sponsor

Battelle Memorial Institute